CCB
BNGO icon

Cutter & Co Brokerage’s Bionano Genomics BNGO Stock Holding History

Cutter & Co Brokerage’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26
Closed -$22.9K – 220
2022
Q4 		$22.9K Sell
26
-69
-73% -$86.8K 0.01% 211
2022
Q3 		$104K Sell
95
-10
-10% -$13.2K 0.04% 206
2022
Q2 		$87K Hold
105
– – 0.03% 215
2022
Q1 		$162K Buy
105
+32
+44% +$43.2K 0.05% 215
2021
Q4 		$131K Buy
73
+19
+35% +$50.8K 0.04% 259
2021
Q3 		$179K Buy
54
+1
+2% +$3.5K 0.04% 276
2021
Q2 		$231K Buy
53
+18
+51% +$71.1K 0.05% 251
2021
Q1 		$170K Buy
+35
New +$197K 0.04% 269

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cutter & Co Brokerage's BNGO Position: Q1 2023 in Review

Cutter & Co Brokerage sold out of Bionano Genomics (BNGO) in Q1 2023, closing a stake of 26 shares — an estimated $22.9K sold.

Cutter & Co Brokerage first reported a position in BNGO in Q1 2021 and held it in 8 quarters. The position peaked at $231K in Q2 2021. 126 funds tracked by Wall St. Rank hold BNGO as of Q1 2023.

  • Cutter & Co Brokerage reported no remaining Bionano Genomics position as of Q1 2023 after selling out during the quarter.
  • Cutter & Co Brokerage sold 26 Bionano Genomics shares in Q1 2023, an estimated $22.9K.
  • Cutter & Co Brokerage first reported a position in Bionano Genomics in Q1 2021 and held it in 8 quarters.
  • Cutter & Co Brokerage's Bionano Genomics position peaked at $231K in Q2 2021.
  • 126 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2023.

Based on Cutter & Co Brokerage's 13F filing for Q1 2023, filed 9 May 2023.